Emergent Biosolutions Inc

NYSE:EBS   12:59:59 PM EDT
+1.07 (+2.48%)
Earnings Announcements

Health Canada Announces Results Of Emergent Biosolutions Facility Inspection

Published: 11/24/2021 17:22 GMT
Emergent Biosolutions Inc (EBS) - :health Canada Announces Results of Emergent Biosolutions Facility Inspection.
Health Canada - All Three Regulators Found Facility to Be Compliant With Good Manufacturing Practices.
Health Canada - European Medicines Agency and South African Health Products Regulatory Authority Also Participated in This Inspection Remotely.
Health Canada - Compliant Rating Means Janssen to Be Able to Import Their Vaccines Into Canada Made With Drug Substance Manufactured at Emergent's Facility.
Revenue is expected to be $628.69 Million
Adjusted EPS is expected to be $4.27

Next Quarter Revenue Guidance is expected to be $297.1 Million
Next Quarter EPS Guidance is expected to be $0.90

More details on our Analysts Page.